CBH is pleased to invite our providers to a webinar on integrated care and addressing diabetes in the Asian population with serious mental illness (SMI).
People with SMI experience premature mortality and die 25 years earlier than the general population, and medications used to treat serious mental illness, such as second-generation antipsychotic medications, can cause metabolic abnormalities, increasing the risk of cardiovascular disease and Type 2 diabetes. Thus, early screening and monitoring of these conditions are critical.
People with SMI who primarily speak an Asian language face additional barriers to receiving adequate screening and treatment for diabetes and cardiovascular disease. As the Asian population continues to grow in Philadelphia, bringing attention to this issue and how to address it with cultural humility has become ever more essential.
This webinar will cover diabetes screening and testing guidelines and will feature a panel discussion about increasing appropriate care in this community.
Medical directors, clinical directors, psychiatrists, nurses, therapists, case managers, and certified peer/recovery specialists are encouraged to participate.
Register by clicking on the website link listed in the details below.